Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen's Imlygic 1st FDA-Approved Oncolytic Virus Therapy
Oct 28 2015
•
By
Donna Young
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Anti-infective
More from Therapeutic Category